Discordant Clinical and Microbiological Outcomes are Associated with Late Clinical Relapse in Clinical Trials for Complicated Urinary Tract Infections (cUTI).

Nadia Kadry,Mukil Natarajan, Edward Bein,Peter Kim,John Farley

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America(2023)

引用 2|浏览0
暂无评分
摘要
Discordant clinical and microbiological outcomes at the TOC visit were associated with an increased risk of late clinical failure. Microbiological outcomes appear to be an important component of the endpoint.
更多
查看译文
关键词
antibacterial drug development,clinical trials,endpoint,urinary tract infection
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要